Efficacy and Safety of Conbercept in Macular Edema Secondary to Retinal Vein Occlusion
Clinical trial NCT01809236 · UNKNOWN
Trial details
- NCT number
- NCT01809236
- Sponsor
- Chengdu Kanghong Biotech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2013-11-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.